Plain-English translation of NCT06527872 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Nephritis research guide →This is a real-world study of belimumab, a medication already approved for treating lupus that affects the kidneys. Researchers want to understand how well this treatment actually works when patients take it as part of their regular care, not in a controlled research setting. The study will look at medical records from about 300 adults to see how the medication affects their kidney health over time.
While this medication has been tested in formal clinical trials, doctors need to understand how it performs in everyday medical practice with diverse patients and different care approaches. This study will help fill that gap by looking at real-world outcomes and helping guide treatment decisions for future patients.
You likely qualify if…
You likely don't qualify if…
This is not a treatment study—you would not be taking a new medication. Instead, researchers would review your medical records from before and after you started this medication as part of your regular care. The study includes both looking back at your past medical information and collecting updated information going forward. You would need to give permission for this record review and may be contacted with follow-up questions about your health.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States
France